These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15580150

  • 1. An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
    Rutgeerts PJ.
    Rev Gastroenterol Disord; 2004; 4 Suppl 3():S3-9. PubMed ID: 15580150
    [Abstract] [Full Text] [Related]

  • 2. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B, Sands BE.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1283-93. PubMed ID: 17059510
    [Abstract] [Full Text] [Related]

  • 3. Perianal fistulizing Crohn's disease: a call to action.
    Kamm MA, Ng SC.
    Clin Gastroenterol Hepatol; 2008 Jan 01; 6(1):7-10. PubMed ID: 18063415
    [Abstract] [Full Text] [Related]

  • 4. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C, Berto E, Scribano ML, Falasco G.
    Ital J Gastroenterol Hepatol; 1998 Dec 01; 30(6):602-6. PubMed ID: 10076781
    [Abstract] [Full Text] [Related]

  • 5. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P.
    Aliment Pharmacol Ther; 2004 Oct 01; 20 Suppl 4():106-10. PubMed ID: 15352905
    [Abstract] [Full Text] [Related]

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 7. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ, Feagan BG, Lichtenstein GR.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):987-1003. PubMed ID: 17877506
    [Abstract] [Full Text] [Related]

  • 8. Current treatment modalities in active Crohn's disease.
    Biancone L, Pallone F.
    Ital J Gastroenterol Hepatol; 1999 Oct 01; 31(6):508-14. PubMed ID: 10575571
    [Abstract] [Full Text] [Related]

  • 9. The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease.
    Rutgeerts P.
    Mediators Inflamm; 1998 Oct 01; 7(3):137-40. PubMed ID: 9705597
    [Abstract] [Full Text] [Related]

  • 10. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.
    Scand J Gastroenterol; 2006 Sep 01; 41(9):1064-72. PubMed ID: 16938720
    [Abstract] [Full Text] [Related]

  • 11. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 01; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 12. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S, van Assche G, Rutgeerts P.
    Aliment Pharmacol Ther; 2007 Jan 01; 25(1):3-12. PubMed ID: 17229216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M.
    Digestion; 2008 Jan 01; 78(4):195-200. PubMed ID: 19122456
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroids in Crohn's disease.
    Yang YX, Lichtenstein GR.
    Am J Gastroenterol; 2002 Apr 01; 97(4):803-23. PubMed ID: 12003413
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of recto-urethral fistulas in Crohn's disease].
    Aiello C, Santoro GA, Cerbone V, de Werra C, Gentile M, Bucci L.
    Minerva Chir; 1997 Sep 01; 52(9):1129-34. PubMed ID: 9432589
    [Abstract] [Full Text] [Related]

  • 17. Managing complicated Crohn's disease in children and adolescents.
    Homan M, Baldassano RN, Mamula P.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec 01; 2(12):572-9. PubMed ID: 16327836
    [Abstract] [Full Text] [Related]

  • 18. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group.
    Gastroenterology; 2007 Aug 01; 133(2):412-22. PubMed ID: 17681162
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 01; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 20. Treatment of fistulizing Crohn's disease.
    Judge TA, Lichtenstein GR.
    Gastroenterol Clin North Am; 2004 Jun 01; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.